MDXG
MiMedx Group
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
MDXG Profile
Mimedx Group, Inc.
A transformational placental biologics company, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare
Biological Technology
Invalid Date
11/04/2020
NASDAQ Stock Exchange
837
12-31
Common stock
1775 West Oak Commons Court
, NE
, Marietta
, GA 30062
--
MiMedx Group, Inc., is incorporated in Florida. The company is a pioneer and leader in placental biologics focused on helping humans heal. With more than a decade of helping clinicians manage chronic and difficult-to-heal wounds, MIMEDX is committed to providing a leading product portfolio for wound care, burns and surgery applications in healthcare. The company's vision is to become the world's leading provider of rehabilitation solutions to restore quality of life through relentless innovation. With deep expertise, leading peer-reviewed data, and an extensive library of additional scientific and real-world evidence in the field of placental biologics, MIMEDX develops and distributes placental tissue allografts, which are manufactured using proprietary, patent-protected processes for multiple sectors of healthcare.